Maria Bortot Email & Phone Number

Switzerland

Basel, Switzerland

- Capitalize on first-rate consulting skills and life sciences industry experience to provide valuable insights to key leaders and clients across the pharmaceutical, life sciences, and medical technologies industries. - Nurture and establish trusting, strong client relationships, sustaining continuous account development and growth. - Take ownership on identifying and securing productive and value-adding business development opportunities. - Command end-to-end lifecycle of projects and its deliverable, including managing project budgets.

San Francisco, California

- Researched treatment trends and commercial opportunities focusing on Hereditary Angioedema and Hemophilia.- Drove discussion guide development, client recruitment, and KOL mapping across US and Europe markets. - Tracked rare disease pharmaceutical products and treatment evolution through extensive primary and secondary research to consolidate and analyze patient treatment data. - Counseled leading biopharmaceutical companies on the dynamics for specific rare disease in target markets.- Built complex models for product tracking, forecasting, and patient-stratification for rare disease products.- Executed comprehensive market and qualitative/quantitative data analysis for data-driven client consultations. - Piloted the progress and timely completion of client deliverables, including strategic regional team management.

Denver Y Alrededores, Estados Unidos

- Assessment of new technologies, including market research- Development of marketing materials to promote new technologies- Collaborate with physicians and scientists in the development and licensing of new technologies

University Of Colorado, Anschutz Medical Campus

- Unraveled mechanisms of acquired von Willebrand Syndrome via microfluidic technology and rheology assays.- Conducted and published clinical studies in the Journal of Atherosclerosis, Thrombosis and Vascular Biology.- Evaluated and quantified bleeding of patient’s cardiopulmonary bypass with a university hospital anesthesiologist for a research study published in The Journal of Cellular and Molecular Bioengineering.- Identified causes of variability in bleeding in severe Haemophilia A with innovative thrombin generation tests’ plasma models, publishing research findings in Journal of Thrombosis and Haemostasis.- Trained 3 professional research assistants and mentored 3 undergraduates for their preferred graduate programs.

Denver, Colorado, United States

- Analyzed the mutation effects in von Willebrand Factor (VWF) gene primary hemostasis via microfluidic technology. - Originated assays to evaluate the interaction between wild type or mutant VWF and several platelet receptors.- Evaluated the design of a novel, linear positive displacement blood pump for cardiopulmonary bypass (Lawson DS, Perfusion, 2017; 32).

Buenos Aires, Argentina

Sydney, Australia

Doctor Of Philosophy - Phd Bioengineering, Hematology

Granted a Pre-Doctoral American Heart Association Fellowship

Masters Bioengineering

Fulbright, International Peace, Entrepreneurship Innovation Scholarships - Worked with the Chief of Orthopedic Surgery to replace current.

Master Of Engineering (Meng), Materials Engineering

Bachelor Of Mechanical Engineering